Diebold (DBD) Tops Q4 EPS by 10c
Tweet
Share
E-mail
Get Alerts DBD Hot Sheet
Price: $67.08 -2.32%
Financial Fact:
Research, development and engineering expense: 17.6M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Research, development and engineering expense: 17.6M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Diebold (NYSE: DBD) reported Q4 EPS of $0.78, $0.10 better than the analyst estimate of $0.68. Revenue for the quarter came in at $615.4 million versus the consensus estimate of $756.74 million.
GUIDANCE:
Diebold sees FY2016 EPS of $1.55-$1.70, versus the consensus of $1.84.
For earnings history and earnings-related data on Diebold (DBD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- JPMorgan Upgrades Lithium Americas Corp. (LAC) to Overweight
- Loop Capital Starts Dave Inc (DAVE) at Buy
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
